Position
Chief Business Officer
Company
NewAmsterdam Pharma
NetherlandsBiotechnologyHealth CareTherapeuticsDescription
NewAmsterdam Pharma Company N.V. announced the appointment of Juliette Audet as Chief Business Officer, effective April 1, 2024. Ms
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Gain Therapeutics Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer (April 1, 2024)
- Aculys Pharma Appoints Hidemasa Tanigaki as Chief Executive Officer and Representative Director (April 1, 2024)
- Dynavax Technologies Corp. Appoints Ryan Spencer as Interim Chief Financial Officer (April 1, 2024)
- Ratio Therapeutics Inc. Appoints Bill Cupelo as Chief Business Officer (April 2, 2024)
- Acadia Pharmaceuticals Appoints Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development (April 2, 2024)
- Q32 Bio Appoints Lee Kalowski as President and Chief Financial Officer (April 3, 2024)
Who to call at NewAmsterdam Pharma, and when
A new leader at NewAmsterdam Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day NewAmsterdam Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NewAmsterdam Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NewAmsterdam Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NewAmsterdam Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NewAmsterdam Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.